About this role
Job title: Small Molecule Bioanalysis Scientist
About the Role We are seeking a full-time, office-based Analytical Chemistry Scientist to join the Bioanalytical Lab in Cincinnati. The role will contribute to the development and validation of LC-MS/MS, GC-MS, ICP-MS, and HPLC methods for small molecule drugs, metabolites, and biomarkers to support preclinical and clinical programs.
What You'll Do
- Develop and validate LC-MS/MS, GC-MS, ICP-MS, and HPLC methods for small molecule drugs, metabolites, and biomarkers.
- Draft study protocols/plans, acquisition methods, and study reports.
- Supervise all phases of bioassays to support pre-clinical and clinical pharmacokinetics, PD biomarkers.
- Supervise technicians for method development, validation, and sample analysis.
- Communicate with internal and external resources for sample receiving, quality control, quality assurance, sponsor correspondence, etc.
What We're Looking For
- PhD in Chemistry, Biochemistry, Pharmaceutical Sciences or related field.
- Previous experience with small molecule drug and drug metabolites analysis.
- Strong project management, compliance, communication, and people skills.
- Experience with various extraction procedures, such as LLE, SPE, SLE+, immune-capture hybrid extraction, etc.
- Experience with LC-MS/MS, GC-MS, ICP-MS, HPLC, etc.
- Direct working experience in Good Laboratory Practices is preferred.
Nice to Have
- Direct working experience in Good Laboratory Practices is preferred.
Compensation & Benefits
- Cincinnati Perks: Flexible work environment.
- Competitive PTO packages, starting at 20+ days.
- Competitive compensation and benefits package.
- Employee health and wellness initiatives.
- Community involvement with local nonprofit organizations.
- Discounts on local sports games, fitness gyms and attractions.
- Modern, ecofriendly campus with an on-site fitness center.
- Structured career paths with opportunities for professional growth.
- Discounted tuition for UC online programs.
- Awards: Named a Top Workplace in 2024 by The Cincinnati Enquirer; Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023 and 2024.